Quantitative bone scan lesion area as an early surrogate outcome measure indicative of overall survival in metastatic prostate cancer-Reference-Cited by-同舟云学术

Quantitative bone scan lesion area as an early surrogate outcome measure indicative of overall survival in metastatic prostate cancer

Published:2018-01-11 Issue:01 Volume:5 Page:1
ISSN:2329-4302
Container-title:Journal of Medical Imaging
language:
Short-container-title:J. Med. Imag.

Author:

Brown Matthew S.¹,Kim Grace Hyun J.¹,Chu Gregory H.¹,Ramakrishna Bharath¹,Allen-Auerbach Martin²,Fischer Cheryce P.³,Levine Benjamin³,Gupta Pawan K.³,Schiepers Christiaan W.²,Goldin Jonathan G.¹

Affiliation:

1. University of California Los Angeles, Center for Computer Vision and Imaging Biomarkers, Los Angeles

2. University of California Los Angeles, Department of Nuclear Medicine, Los Angeles, California

3. University of California Los Angeles, Department of Radiological Sciences, Los Angeles, California

Publisher

SPIE-Intl Soc Optical Eng

Subject

Radiology, Nuclear Medicine and imaging

Reference26 articles.

1. Cancer

2. Understanding the Biology of Bone Metastases: Key to the Effective Treatment of Prostate Cancer

3. Metastatic bone disease: clinical features, pathophysiology and treatment strategies

4. Managing metastatic bone disease: Three case studies

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The safety of radium-223 combined with new-generation hormonal agents in bone metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis;Asian Journal of Andrology;2023

2. Pretreatment visceral metastases in castration resistant metastatic prostate cancer: role in prediction versus actual site of disease progression;Cancer Imaging;2022-07-14

3. Bone radiomics reproducibility: a three-centered study on the impacts of image contrast, edge enhancement, and latitude variations;Physical and Engineering Sciences in Medicine;2022-04-07

4. Deep Learning for the Automatic Diagnosis and Analysis of Bone Metastasis on Bone Scintigrams;Cancer Management and Research;2022-01

5. Decreased enrollment in breast cancer trials by histologic subtype: does invasive lobular carcinoma resist RECIST?;npj Breast Cancer;2021-10-25